Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule... Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. 詳細を表示
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.2 | -6.94444444444 | 17.28 | 18.07 | 15.75 | 633851 | 16.9370881 | CS |
4 | 1.88 | 13.2394366197 | 14.2 | 18.09 | 14.15 | 646306 | 16.15595083 | CS |
12 | 0.34 | 2.16010165184 | 15.74 | 18.98 | 14.15 | 733814 | 16.54792745 | CS |
26 | -0.79 | -4.68286899822 | 16.87 | 18.98 | 13.52 | 694790 | 16.21307759 | CS |
52 | -1.94 | -10.7658157603 | 18.02 | 20.31 | 13.52 | 722589 | 16.63091061 | CS |
156 | -22.58 | -58.4066218314 | 38.66 | 45.9 | 12.95 | 870452 | 21.76872503 | CS |
260 | 7.43 | 85.8959537572 | 8.65 | 49.1 | 8.19 | 745528 | 23.81466218 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約